Connie Swanson

Alaven Pharmaceutical LLC develops and markets prescription and non-prescription products. The company was founded on August 01, 2003 and is headquartered in Somerset, NJ.

Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA.

Arcuo Medical, Inc. manufactures surgical and medical instruments.

BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA.

Arbor Vita Corp. engages in discovery and developing of drugs. It targets cellular regulators, PDZ proteins, to accelerate the discovery and development of human therapeutics, and diagnostics. The company was founded by Peter S. Lu in 1998 and is headquartered in Fremont, CA.

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.

Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA.

Part of Fresenius Medical Care AG, Dialysis Centers of America, Inc. is a company that operates 12 dialysis centers. The company is based in Chicago, IL. Dialysis Centers of America was acquired by Renal Care Group, Inc., part of Fresenius Medical Care AG from January 03, 2007 on February 03, 1999 for $90.82 million.

Grady Memorial Hospital operates a hospital. The private company is based in Delaware, OH. John M. Haupert has been the CEO of the company since 2011.

NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation.

Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ.

Achelios Therapeutics, Inc. operates as a bio-pharmaceutical development company. It specializes in non-steroidal anti-inflammatory drug. The company was founded by Crist J. Frangakis and is headquartered in Chaple Hill, NC.

Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019.

Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA.

Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California.

A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA.

Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.